Cancer Research Institute

08/18/2025

“Ultraviolet radiation is a known carcinogen; there is no debate about that,” empasizes The George Washington University's Dr. Adam Friedman. “We’ve had decades of data showing that sunscreen plays a critical role in reducing skin cancer risk.” Debunk sunscreen myths this summer, with Washington Post: https://wapo.st/3UpAeHh

A growing anti-sunscreen movement on social media is causing concern among dermatologists, who warn that avoiding sunscreen increases long-term health risks.

08/17/2025

Why are colorectal cancer rates rising in young adults? "Since the mid-1990s," The Independent emphasizes, "there has been a consistent annual increase of 2% in cases among American adults between the ages of 20-39, the Cancer Research Institute reports." Explore:

Major increase in colorectal cancer in younger adults tied to pandemic years, researchers say - There has been a recent surge in colorectal cancer cases and deaths in young adults around the world. But researchers still don’t quite know why

08/16/2025

💜 Hear directly from three cancer survivors, during CRI's Patient Roundtable, and gain the insight and answers you need to navigate your own cancer journey, in Hope in Action: A Patient’s Guide to Cancer Immunotherapy. Discover now: https://bit.ly/4kZWQZC

At the Cancer Research Institute (CRI), we know that the moment a person hears “you have cancer,” everything changes. However, what comes next—fear or hope, isolation or connection—can depend on access to something powerful: information.

08/15/2025

☀️ Did you know? Skin cancer is the most common type of cancer in the US. This summer, Outside Magazine shares what you need to know about sun exposure and skin cancer: https://bit.ly/41v3vE7

Skin cancer rates are rising and one in five Americans will be diagnosed with it before the age of 70

08/14/2025

Who benefits most from immunotherapy, and why doesn't it work for everyone? Understand what shapes immunotherapy's efficacy, and review the potential benefits, side effects, and risks of this treatment type, with OncoDaily:

Discover the immunotherapy for cancer success rate across tumor types, based on clinical trials and real-world data. A patient guide to outcomes and expectations.

08/13/2025

🌟 When everything feels out of control, mindset matters.

During CRI's Patient Roundtable, cancer survivors Karen, Tom, and Brendan share what helped them stay grounded during the hardest moments, from Superman shirts to radical self-care.

Explore additional chapters of their conversation, on demand, on our website: https://bit.ly/4kz4uut

08/12/2025

As cancer research advances through cutting-edge technologies such as data science and immunotherapy, the way we fund this work must keep pace. CRI has always relied on bold, forward-thinking donors to drive progress—and today, that includes those embracing new tools like cryptocurrency! Explore this new frontier of philanthropic giving: https://bit.ly/4fxf8QE

We've always relied on bold, forward-thinking donors to drive progress--and today, that includes those embracing new tools like cryptocurrency.

08/11/2025

Why is immunotherapy succesful for some patients, and not for others?

New research from investigators at Yale School of Medicine demonstrates that naturally occurring autoantibodies can boost or hinder cancer immunotherapy effectiveness by up to 10-fold, providing new insights into why immunotherapy may work only for some patients. Explore:

08/10/2025

How could the success rate of cancer immunotherapy, and a common artificial sweetener, be linked?

In a new study, researchers from University of Pittsburgh and UPMC Hillman Cancer Center including CRI Lloyd J. Old STAR Dr. Greg Delgoffe found that patients with melanoma and non-small cell lung cancer who consumed high levels of sucralose had worse response to immunotherapy and poorer survival than those with diets low in the artificial sweetener.

Learn more:

This Artificial Sweetener Could Make Cancer Treatment Less Effective

08/09/2025

🎗️ Every cancer diagnosis is different, but CRI ImmunoAdvocates Karen, Tom, and Brendan each shared a common shield in their cancer battle: information. Hear directly from these cancer survivors, during CRI's Patient Roundtable, and gain the insight and answers you need to navigate your own cancer journey, in Hope in Action: A Patient’s Guide to Cancer Immunotherapy: https://bit.ly/4kZWQZC

At the Cancer Research Institute (CRI), we know that the moment a person hears “you have cancer,” everything changes. However, what comes next—fear or hope, isolation or connection—can depend on access to something powerful: information.

08/08/2025

Did you know? "Use of FDA-approved cancer immunotherapies increased more than tenfold between 2015 and 2017," Becker's Hospital Review describes. "The use of immune-checkpoint-inhibitors — which account for 81% of currently FDA approved immunotherapies — increased more than twentyfold by 2024, according to the Cancer Research Institute." Dive deeper into the field of immunotherapy:

From cell-manufacturing laboratories to outpatient infusion facilities, health systems are rapidly adapting to a new kind of cancer treatment that demands individualized care, infrastructure and training: immunotherapy.  To better navigate the complex and strategic considerations presented by immun...

08/07/2025

"Now, 8 years after beginning immunotherapy, John’s scans show no signs of disease. He has been off all treatment for almost 2 years," Tufts Medicine describes. Discover CRI ImmunoAdvocate John's story of survival: https://bit.ly/46kH9IT

Tufts MC metastic prostate cancer survivor becomes advocate